Search Records

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

The Government of Canada is working on all possible fronts to secure access to safe and effective vaccines and related supplies for Canadians. Here is what Canadians need to know about a future COVID-19 vaccine.

The National Microbiology Laboratory (NML) provides critical scientific leadership for Canada’s response to COVID-19.

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

In 2018, 50% of Canadians had never been tested for HIV, hepatitis C, or STI.

"FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.

Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This...